Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Circulating sclerostin and Dickkopf-1 levels in patients with nonalcoholic fatty liver disease..
J Bone Miner Metab. 34(4), 447-56.
(2016). Helicobacter pylori infection in patients with nonalcoholic fatty liver disease..
Metabolism. 62(1), 121-6.
(2013). Adipocytokines in insulin resistance and non-alcoholic fatty liver disease: the two sides of the same coin..
Med Hypotheses. 74(6), 1089-90.
(2010). Acute transient thyroid swelling following needle biopsy: an update..
Hormones (Athens). 11(2), 147-50.
(2012). Nonalcoholic fatty liver disease and hepatocellular carcinoma:Insights in epidemiology, pathogenesis, imaging, prevention and therapy..
Semin Cancer Biol. 93, 20-35.
(2023). Circulating homocysteine in nonalcoholic fatty liver disease..
Eur J Intern Med. 26(2), 152-3.
(2015). Serum homocysteine levels in patients with nonalcoholic fatty liver disease..
Ann Hepatol. 11(1), 68-76.
(2012). Obesity: seize the day, fight the fat..
Metabolism. 92, 1-5.
(2019). Clinical vertebral fractures following denosumab discontinuation..
Endocrine. 54(1), 271-272.
(2016). Prolonged anti-resorptive activity of zoledronic acid: evidence from postmenopausal osteopenic women and patients with Paget's disease of bone..
Clin Rheumatol. 30(1), 149-50.
(2011). Helicobacter pylori infection and serum adiponectin..
Helicobacter. 18(4), 321-2.
(2013). Nonalcoholic fatty liver disease: Is it time for combination treatment and a diabetes-like approach?.
Hepatology. 68(1), 389.
(2018). Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease..
J Clin Gastroenterol. 46(4), 272-84.
(2012). Nonalcoholic fatty liver disease: the pathogenetic roles of insulin resistance and adipocytokines..
Curr Mol Med. 9(3), 299-314.
(2009). Dual-energy X-ray absorptiometry and quantitative ultrasound in patients with Paget's disease of bone before and after treatment with zoledronic acid: association with serum bone markers and Dickkopf-1..
J Clin Densitom. 13(2), 190-6.
(2010). Lipodystrophy: Time for a global registry and randomized clinical trials to assess efficacy, safety and cost-effectiveness of established and novel medications..
Metabolism. 72, A4-A10.
(2017). Juvenile Paget disease..
Metabolism. 80, 15-26.
(2018). Effect of Helicobacter pylori eradication on hepatic steatosis, NAFLD fibrosis score and HSENSI in patients with nonalcoholic steatohepatitis: a MR imaging-based pilot open-label study..
Arq Gastroenterol. 51(3), 261-8.
(2014). Alterations in serum thyroid-related constituents after thyroid fine-needle biopsy: a systematic review..
Thyroid. 20(3), 265-71.
(2010). Leptin in nonalcoholic fatty liver disease: a narrative review..
Metabolism. 64(1), 60-78.
(2015). Review article: non-alcoholic fatty liver disease and cardiovascular diseases: associations and treatment considerations..
Aliment Pharmacol Ther.
(2021). Infectious thyroiditis as a complication of fine-needle biopsy: a systematic review..
Expert Rev Endocrinol Metab. 5(5), 673-679.
(2010). Normal bone turnover markers in a patient with active Paget's disease of bone: response to treatment with zoledronic acid..
Endokrynol Pol. 63(4), 312-5.
(2012).
(2020).
(2015).